Facility Agreements in the Pharmaceuticals Industry

31 Contracts & Agreements

Browse by Company

Aralez Pharmaceuticals Inc. (1 contract)
AVENUE THERAPEUTICS, INC. (1)
Intersect ENT, Inc. (4)
ISTA PHARMACEUTICALS INC (1)
KEMPHARM, INC (13)
MiddleBrook Pharmaceuticals, Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
Neos Therapeutics, Inc. (6)
Osmotica Pharmaceuticals plc (1)
Tilray, Inc. (1)
TITAN PHARMACEUTICALS INC (1)

Recent Contracts

DIP Facility Agreement, dated as of October 16, 2023, by and between the Debtors, Athyrium Opportunities IV Acquisition LP, as administrative agent and collateral agent, and... (Osmotica Pharmaceuticals plc, Filed With SEC on October 20, 2023)
Amendment No. 1 to Facility Agreement, dated as of April 15, 2022, by and among Intersect ENT, Inc., certain of Intersect ENT, Inc.s subsidiaries from time to time party thereto... (Intersect ENT, Inc., Filed With SEC on April 18, 2022)
Facility Agreement, dated as of September 25, 2021, by and among Intersect ENT, Inc., certain of Intersect ENT, Inc.s subsidiaries from time to time party thereto as guarantors... (Intersect ENT, Inc., Filed With SEC on September 27, 2021)
Facility Agreement, dated as of July 22, 2021, by and among Intersect ENT, Inc., certain of Intersect ENT, Inc (Intersect ENT, Inc., Filed With SEC on July 22, 2021)
Facility Agreement, dated June 12, 2020, by and between Avenue Therapeutics, Inc., InvaGen Pharmaceuticals Inc., and Fortress Biotech, Inc (AVENUE THERAPEUTICS, INC., Filed With SEC on August 14, 2020)
Facility Agreement, dated as of May 11, 2020, by and among Intersect ENT, Inc., certain of Intersect ENT, Inc.s subsidiaries from time to time party thereto as guarantors and... (Intersect ENT, Inc., Filed With SEC on May 11, 2020)
Fifth Amendment to Facility Agreement, dated as of May 6, 2020, by and among Neos Therapeutics, Inc., the guarantor parties thereto, Deerfield Private Design Fund III, L.P. and... (Neos Therapeutics, Inc., Filed With SEC on May 7, 2020)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 30, 2019 (KEMPHARM, INC, Filed With SEC on November 14, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 23, 2019 (KEMPHARM, INC, Filed With SEC on November 14, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 16, 2019 (KEMPHARM, INC, Filed With SEC on November 14, 2019)
Fourth Amendment to the Facility Agreement, dated as of October 2, 2019, by and between Deerfield Private Design Fund III, L.P., Deerfield Special Situations Fund, L.P. and... (Neos Therapeutics, Inc., Filed With SEC on October 3, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated August 9, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 31, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated July 15, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 28, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 24, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 17, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Amendment to Facility Agreement, by and between Registrant and Deerfield Private Design Fund III, L.P., dated June 3, 2019 (KEMPHARM, INC, Filed With SEC on August 13, 2019)
Third Amendment to Facility Agreement dated as of March 26, 2019 by and among the Registrant, Deerfield Private Design Fund III, L.P., and Deerfield Special Situations Fund, L.P (Neos Therapeutics, Inc., Filed With SEC on May 10, 2019)
Second Amendment to Facility Agreement, dated as of November 5, 2018, by and among Neos Therapeutics, Inc., Deerfield Private Design Fund III, L.P. and Deerfield Special Situation... (Neos Therapeutics, Inc., Filed With SEC on November 5, 2018)
Construction Facility Agreement between Privateer Holdings, Inc. and Bouchard Ventures, Ltd., dated November 1, 2017 (Tilray, Inc., Filed With SEC on June 20, 2018)
FIRST AMENDMENT TO FACILITY AGREEMENT (Neos Therapeutics, Inc., Filed With SEC on June 5, 2017)
AMENDMENT TO SECOND AMENDED AND RESTATED FACILITY AGREEMENT (Aralez Pharmaceuticals Inc., Filed With SEC on October 7, 2016)
FACILITY AGREEMENT (Neos Therapeutics, Inc., Filed With SEC on August 12, 2016)
SECONDAMENDMENT TO FACILITY AGREEMENT (KEMPHARM, INC, Filed With SEC on December 18, 2015)
SECOND AMENDMENT TO FACILITY AGREEMENT (KEMPHARM, INC, Filed With SEC on December 18, 2015)
FACILITY AGREEMENT (KEMPHARM, INC, Filed With SEC on March 11, 2015)
FACILITY AGREEMENT (TITAN PHARMACEUTICALS INC, Filed With SEC on March 18, 2011)
FACILITY SETUP AND CONTRACT MANUFACTURING AGREEMENT between Eckert & Ziegler Nuclitec GmbH Gieselweg 1 38110 Braunschweig (Molecular Insight Pharmaceuticals, Inc., Filed With SEC on November 9, 2009)
FACILITY AGREEMENT (ISTA PHARMACEUTICALS INC, Filed With SEC on September 30, 2008)
FACILITY BUILD-OUT AGREEMENT (MiddleBrook Pharmaceuticals, Inc., Filed With SEC on August 15, 2005)